netFormulary NHS
Lancashire and South Cumbria
Formulary
 Search
 Results

Looking for Tirzepatide found 8 matches
Open monograph to display formulary status BNF Category
  Tirzepatide Endocrine system - GLP1 agonists - 06.01.02.03
  Tirzepatide  (Mounjaro®) Central nervous system - Anti-obesity drugs acting on the gastro-intestinal tract - 04.05.01
  Tirzepatide  (Mounjaro®) Central nervous system - Anti-obesity drugs acting on the gastro-intestinal tract - 04.05.01
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section LSCMMG: Mounjaro® (Tirzepatide) for Type 2 Diabetes Position Statement (06.01.02.03)
link in drug section LSCMMG: Tirzepatide for managing overweight and obesity position statement (04.05.01)
link in drug section NICE TA924: Tirzepatide for treating type 2 diabetes (06.01.02.03)
link in drug section Tirzepatide: LSC ICB specialist weight management support in Lancashire and South Cumbria (June 2025) (04.05.01)
link in drug section Tirzepatide: Mounjaro® (tirzepatide) for managing overweight and obesity in primary care (06.01.02.03)




Document Library Items Found
Document links All Pathways and Guidance (Tirzepatide for Type 2 Diabetes position statement)
Document links All Pathways and Guidance (Tirzepatide: LSC ICB specialist weight management support in Lancashire and South Cumbria (June 2025))
Document links All Pathways and Guidance (Tirzepatide: Mounjaro® (tirzepatide) for managing overweight and obesity in primary care)

 
netFormulary